Bioequivalence and Bioavailability Forum 07:35 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

TRT / RTR Design [RSABE / ABEL]

posted by mittyri - Russia, 2017-05-02 18:38  - Posting: # 17295
Views: 5,032

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

» The appropriate sample size must be.
» Alpha correction.
what did you mean here?

Kind regards,
Mittyri

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,016 posts in 4,056 threads, 1,297 registered users;
online 15 (1 registered, 14 guests [including 10 identified bots]).

The only people who see the whole picture are the ones
who step out of the frame.    Salman Rushdie

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed